Anti-tumor necrosis factor alpha therapy suppresses the induction of experimental autoimmune uveoretinitis in mice by inhibiting antigen priming

Investigative Ophthalmology and Visual Science

Volumn 37, Issue 11, 1996, Pages 2211-2218

  Sartani, Gil ^a   Silver, Phyllis B ^a   Rizzo, Luiz V ^a   Chan, Chi Chao ^a   Wiggert, Barbara ^b   Mastorakos, George ^c   Caspi, Rachel R ^a,b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL EYE INSTITUTE   (United States)

^c EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

antibodies; autoimmune disease; experimental autoimmune uveitis (EAU); mouse; tumor necrosis factor (TNF); uveitis

Indexed keywords

IMMUNOGLOBULIN; POLYCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; DRUG THERAPY; IMMUNIZATION; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PREVENTION; PRIORITY JOURNAL; SPLEEN CELL; UVEORETINITIS;

ANIMALS; ANTIBODIES; AUTOANTIGENS; AUTOIMMUNE DISEASES; DISEASE MODELS, ANIMAL; EYE PROTEINS; FEMALE; HYPERSENSITIVITY, DELAYED; IMMUNIZATION; LYMPHOCYTE ACTIVATION; MICE; RABBITS; RECOMBINANT PROTEINS; RETINITIS; RETINOL-BINDING PROTEINS; TUMOR NECROSIS FACTOR-ALPHA; UVEITIS, POSTERIOR;

EID: 0029821210     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Gery I, Mochizuki M, Nussenblatt RB. Retinal specific antigens and immunopathogenic processes they provoke. Prog Retinal Res. 1986;5:75-79.
2. Caspi RR. Basic mechanisms in immune-mediated uveitic disease. In: Lightman SL, ed. Immunology of Eye Disease. Lancaster UK: Kluwer; 1989:61-86.
3. Nussenblatt RB, Palestine AG. Uveitis: Fundamentals and Clinical Practice. Chicago: Year Book Medical Publishers; 1989.
4. Old LJ. Tumor necrosis factor (TNF). Science. 1985; 230:630-632.
5. Beutler B, Cerami A. The biology of cachectin/TNF - a primary mediator of the host response. Annu Rev Immunol. 1989;7:625-655.
6. Sherry B, Cerami A. Cachectin/tumor necrosis factor exerts endocrine, paracrine, and autocrine control of inflammatory responses. J Cell Biol. 1988;107:1269-1277.
7. Kunkel SL, Remick DG, Strieter RM, Larrick JW. Mechanisms that regulate the production and effects of tumor necrosis factor-alpha. Crit Rev Immunol. 1989;9:93-117.
8. Carswell EA, Old LJ, Kassel RL, Green S, Fiore N, Williamson B. An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci USA. 1975;72:3666-3670.
9. Fisch H, Gifford GE. In vitro production of rabbit macrophage tumor cell cytotoxin. Int J Cancer. 1983;32:105-112.
10. Cuturi MC, Murphy M, Costa-Giomi MP, Weinmann R, Perussia B, Trinchieri G. Independent regulation of tumor necrosis factor and lymphotoxin production by human peripheral blood lymphocytes. J Exp Med. 1987;165:1581-1594.
11. Degliantoni G, Murphy M, Kobayashi M, Francis MK, Perussia B, Trinchieri G. Natural killer (NK) cell-derived hematopoietic colony-inhibiting activity and NK cytotoxic factor: Relationship with tumor necrosis factor and synergism with immune interferon. J Exp Med. 1985;162:1512-1530.
12. Fong Y, Lowry SF. Tumor necrosis factor in the pathophysiology of infection and sepsis. Clin Immunol Immunopathol. 1990;55:157-170.
13. Yokota S, Geppert TD, Lipsky PE. Enhancement of antigen- and mitogen-induced human T lymphocyte proliferation by tumor necrosis factor-alpha. J Immunol. 1988;140:531-536.
14. Salyer JL, Bohnsack JF, Knape WA, Shigeoka AO, Ashwood ER, Hill HR. Mechanisms of tumor necrosis factor-alpha alteration of PMN adhesion and migration. Am J Pathol. 1990;136:831-841.
15. Panzer S, Madden M, Matsuki K. Interaction of IL-1 beta, IL-6 and tumour necrosis factor-alpha (TNF-alpha) in human T cells activated by murine antigens. Clin Exp Immunol. 1993;93:471-478.
16. Carlos TM, Schwartz BR, Kovach NL, et al. Vascular cell adhesion molecule-1 mediates lymphocyte adherence to cytokine-activated cultured human endothelial cells [published erratum appears in Blood 1990;76:2420]. Blood. 1990;76:965-970.
17. Fleisher LN, Ferrell JB, McGahan MC. Ocular inflammatory effects of intravitreally injected tumor necrosis factor-alpha and endotoxin. Inflammation. 1990;14:325-335.
18. Portillo G, Turner M, Chantry D, Feldmann M. Effect of cytokines on HLA-DR and IL-1 production by a monocytic tumour, THP-1. Immunology. 1989;66:170-175.
19. Brosnan CF, Selmaj K, Raine CS. Hypothesis: A role for tumor necrosis factor in immune-mediated demyelination and its relevance to multiple sclerosis. J Neuroimmunol. 1988;18:87-94.
20. Hintzen RQ, Polman CH, Lucas CJ, van Lier RA. Multiple sclerosis: Immunological findings and possible implications for therapy. J Neuroimmunol. 1992;39:1-10.
21. Kulkarni PS, Srinivasin BD: Cachectin: A novel polypeptide induces uveitis in the rabbit eye. Exp Eye Res. 1988;46:631-633.
22. Rosenbaum JT, Howes EL Jr, Rubin RM, Samples JR. Ocular inflammatory effects of intravitreally-injected tumor necrosis factor. Am J Pathol 1988;133:47-53.
23. De Vos AF, Hoekzema R, Kijlstra A. Cytokines and uveitis, a review. Curr Eye Res. 1992;11:581-597.
24. Nakamura S, Yamakawa T, Sugita M, et al. The role of tumor necrosis factor-alpha in the induction of experimental autoimmune uveoretinitis in mice. Invest Ophthalmol Vis Sci. 1994;35:3884-3889.
25. Franks WA, Limb GA, Stanford MR, et al. Cytokines in human intraocular inflammation, Curr Eye Res. 1992; 11(suppl):187-191.
26. Pepperberg DR, Okajima TL, Ripps H, Chader GJ, Wiggert B. Functional properties of interphotoreceptor retinoid-binding protein. Photochem Photobiol. 1991;54:1057-1060.
27. Schurmeyer TH, Avgerinos PC, Gold PW, et al. Human corticotropin-releasing factor in man: Pharmacokinetic properties and dose-response of plasma adrenocorticotropin and cortisol secretion. J Clin Endocrinol Metab. 1984;59:1103-1108.
28. Karalis K, Sano H, Redwine J, Listwak S, Wilder RL, Chrousos GP. Autocrine or paracrine inflammatory actions of corticotropin-releasing hormone in vivo. Science. 1991;254:421-423.
29. Caspi RR, Roberge FG, Chan CC, et al. A new model of autoimmune disease: Experimental autoimmune uveoretinitis induced in mice with two different retinal antigens. J Immunol. 1988;140:1490-1495.
30. Caspi RR, Fujino Y, Najafian F, Grover S, Hansen CB, Wilder RL. Recruitment of antigen-nonspecific cells plays a pivotal role in the pathogenesis of a T cell-mediated organ-specific autoimmune disease, experimental autoimmune uveoretinitis. J Neuroimmunol. 1993;47:177-188.
31. Snedecor GW, Cochran WG. Statistical Methods. 6th ed. Ames, IA: Iowa State University Press; 1967:248-248.
32. Caspi RR, Roberge FG, McAllister CG, et al. T cell lines mediating experimental autoimmune uveoretinitis (EAU) in the rat. J Immunol. 1986;136:928-933.
33. Piguet PF, Grau GE, Vesin C, Loetscher H, Gentz R, Lesslauer W. Evolution of collagen arthritis in mice is arrested by treatment with anti-tumour necrosis factor (TNF) antibody or a recombinant soluble TNF receptor. Immunology. 1992;77:510-514.
34. Yang XD, Tisch R, Singer SM, et al. Effect of tumor necrosis factor alpha on insulin-dependent diabetes mellitus in NOD mice: I: The early development of autoimmunity and the diabetogenic process. J Exp Med. 1994;180:995-1004.
35. Smith SC, Allen PM. Neutralization of endogenous tumor necrosis factor ameliorates the severity of myosin-induced myocarditis. Circ Res. 1992;70:856-863.
36. Bromberg JS, Chavin KD, Kunkel SL. Anti-tumor necrosis factor antibodies suppress cell-mediated immunity in vivo. J Immunol. 1992;148:3412-3417.
37. Powell MB, Mitchell D, Lederman J, et al. Lymphotoxin and tumor necrosis factor-alpha production by myelin basic protein-specific T cell clones correlates with encephalitogenicity. Int Immunol. 1990;2:539-544.
38. Ruddle NH, Bergman CM, McGrath KM, et al. An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis. J Exp Med. 1990;172:1193-1200.
39. Sarin A, Conan-Cibotti M, Henkart PA. Cytotoxic effect of TNF and lymphotoxin on T lymphoblasts. J Immunol. 1995;155:3716-3718.
40. Zheng L, Fisher G, Miller RE, Peschon J, Lynch DH, Lenardo MJ. Induction of apoptosis in mature T cells by tumour necrosis factor. Nature. 1995;377:348-351.
41. de Kozak Y, Naud MC, Bellot J, Faure JP, Hicks D. Differential tumor necrosis factor expression by resident retinal cells from experimental uveitis-susceptible and -resistant rat strains. J Neuroimmunol. 1994; 55:1-9.
42. Selmaj K, Papierz W, Glabinski A, Kohno T. Prevention of chronic relapsing experimental autoimmune encephalomyelitis by soluble tumor necrosis factor receptor I. J Neuroimmunol. 1995;56:135-141.
43. Otsuka Y, Nagano K, Nagano K, et al. Inhibition of neutrophil migration by tumor necrosis factor: Ex vivo and in vivo studies in comparison with in vitro effect. J Immunol. 1990;145:2639-2643.
44. Feldmann M, Brennan FM, Chantry D, et al. Cytokine assays: Role in evaluation of the pathogenesis of autoimmunity. Immunol Rev. 1991;119:105-123.
45. Flesch IE, Hess JH, Huang S, et al. Early interleukin 12 production by macrophages in response to mycobacterial infection depends on interferon gamma and tumor necrosis factor alpha. J Exp Med. 1995;181: 1615-1621.
46. Rizzo LV, Silver PB, Hakim F, et al. Establishment and characterization of an IRBP-specific T cell line and clone that induce experimental autoimmune uveoretinitis in B10-A mice. J Immunol. 1996;156:1654-1660.
47. Rizzo LV, Silver PB, Gazzinelli RT, Chan CC, Wiggert B, Caspi RR. Expression of cytokine genes within the eye in murine EAU. ARVO Abstracts. Invest Ophthalmol Vis Sci. 1994;34:1862.
48. Savion S, Oddo S, Grover S, Caspi RR. Uveitogenic T lymphocytes in the rat: Pathogenicity vs. lymphokine production, adhesion molecules and surface antigen expression. J Neuroimmunol. 1994;55:35-44.